Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
Nico H. van Tilburg(Leiden University Medical Center), Rogier M. Bertina(Leiden University Medical Center), Frits R. Rosendaal(Leiden University Medical Center)
Cited by 373
Related Papers
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k